The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
Open accessAbstract
The kinetic parameters, steroid substrate specificity and identities of reaction products were determined for four homogeneous recombinant human 3α-hydroxysteroid dehydrogenase (3α-HSD) isoforms of the aldo-keto reductase (AKR) superfamily. The enzymes correspond to type 1 3α-HSD (AKR1C4), type 2 3α(17β)-HSD (AKR1C3), type 3 3α-HSD (AKR1C2) and 20α(3α)-HSD (AKR1C1), and share at least 84% amino acid sequence identity. All enzymes acted as NAD(P)(H)-dependent 3-, 17- and 20-ketosteroid reductases and as 3α-, 17β- and 20α-hydroxysteroid oxidases. The functional plasticity of these isoforms highlights their ability to modulate the levels of active androgens, oestrogens and progestins. Salient features were that AKR1C4 was the most catalytically efficient, with kcat/Km values for substrates that exceeded those obtained with other isoforms by 10–30-fold. In the reduction direction, all isoforms inactivated 5α-dihydrotestosterone (17β-hydroxy-5α-androstan-3-one; 5α-DHT) to yield 5α-androstane-3α,17β-diol (3α-androstanediol). However, only AKR1C3 reduced ∆4-androstene-3,17-dione to produce significant amounts of testosterone. All isoforms reduced oestrone to 17β-oestradiol, and progesterone to 20α-hydroxy-pregn-4-ene-3,20-dione (20α-hydroxyprogesterone). In the oxidation direction, only AKR1C2 converted 3α-androstanediol to the active hormone 5α-DHT. AKR1C3 and AKR1C4 oxidized testosterone to ∆4-androstene-3,17-dione. All isoforms oxidized 17β-oestradiol to oestrone, and 20α-hydroxy…
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“17HSD5 may account for much of the extratesticular, peripheral conversion of androstenedione to testosterone, although its catalytic efficiency as a 17HSD is poor (528) compared with its 20␣HSD activity with progesterone and DOC (520) or its prostaglandin dehydrogenase activity, reducing prostaglandin H 2 to prostaglandin F 2␣ (529).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [528]
In the citing paper
“AKR1C1-AKR1C4 act as 3-keto, 17-keto and 20-ketosteroid reductases to varying extents”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C enzymes (AKR1C1-AKR1C4) function in vivo as 3-keto-, 17-keto- and 20-ketosteroid reductases to form 3α/β, 17β- and 20α-hydroxy-metabolites to varying extents and thus metabolize a broad spectrum of natural and synthetic therapeutic steroids”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“These enzymes are expressed in different tissues, while AKR1C4 is mainly liver specific”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C1, but also AKR1C2 and AKR1C3 catalyze progesterone reduction to form the less potent progestagen 20α-hydroxy-pregn-4-ene-3-one”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C3 is the most efficient enzyme for this reaction (KM = 9 μM, kcat = 0.068 mM−1; kcat/KM = 76 min−1 mm−1).”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C enzymes also act as 17-ketosteroid reductases to reduce the weak estrogen, estrone to form the potent estrogen, 17β-estradiol in peripheral tissues”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“Other AKR1C enzymes have much lower activities for 17β-estradiol formation”
From Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism (2014) · cites this paper as [14]
In the citing paper
“AKR1C enzymes are multifunctional and also function as 20α- and 17β-HSDs, with different efficiencies, stereoselectivities and tissue specific expression [104].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [104]
In the citing paper
“the direct 20α-reduction of progesterone terminates its progestogenic activity”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [104]
In the citing paper
“is predominantly catalyzed by AKR1C1 [104,115].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [104]
In the citing paper
“AKR1C1 is the predominant 20-ketosteroid reductase in human [104].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical estimations in enzyme kinetics
Wilkinson, G. (1961) · Biochemical Journal · doi:10.1042/bj0800324 · Cited by 3,535
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
Majewska, M. D. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90025-a · Cited by 1,089
Neurosteroids and GABAA receptor function
Lambert, J. J., Belelli, D., Hill-Venning, C., & Peters, J. A. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89058-6 · Cited by 746
Comparative anatomy of the aldo–keto reductase superfamily
Jez, J. M., BENNETT, M. J., Schlegel, B. P., Lewis, M., & Penning, T. M. (1997) · Biochemical Journal · doi:10.1042/bj3260625 · Cited by 603
Self-citationThe key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
Labrie, F., Luu-The, V., Lin, S.-X., Claude, L., Simard, J., Breton, R., & Bélanger, A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00174-2 · Cited by 480
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
Griffin, L. D., & Mellon, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13512 · Cited by 387
A new nomenclature for the aldo-keto reductase superfamily
Jez, J. M., Flynn, T. G., & Penning, T. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)84253-0 · Cited by 350
Self-citationDanielsson, H., & Sjövall, J. (1975) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.44.070175.001313 · Cited by 272
Steroid Structure and Androgenic Activity
Liao, S., Liang, T., Fang, S., Castañeda, E., & Shao, T.-C. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43521-7 · Cited by 265
Research works printed but not linked: 2
- 29 Leatherbarrow, R. J. (1987) ENZFITTER: A non-linear regression data analysis program for the IBM PC (and true compatibles), BioSoft, Cambridge, U.K.
- 33 Lin, H.-K., Jez, J. M., Overby, A. M., Burczynski, M. E., Peehl, D. M. and Penning, T. M. (2000) Type 3 3 a -hydroxysteroid dehydrogenase (3 a -HSD) accumulates 5 a -DHT and activates the androgen receptor in human prostate cancer PC3 cells. Proc. Am. Assoc. Cancer. Res. 41 , Abstract 1510
Cited by
Sorted by citations
Items 401–500 of 671
Progesterone Metabolism by Human and Rat Hepatic and Intestinal Tissue
Coombes, Z., Plant, K., Freire, C., Basit, A. W., Butler, P. J., Conlan, R. S., & González, D. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101707 · Cited by 16
5β-Dihydrosteroids: Formation and Properties
Penning, T. M., & Covey, D. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168857 · Cited by 15
Self-citationYang, L., Zhang, J., Zhang, S., Dong, W., Lou, X., & Liu, S. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.04.001 · Cited by 15
Xia, D., Lai, D. V., Wu, W., Webb, Z. D., Yang, Q., Zhao, L., Yu, Z., Thorpe, J. E., Disch, B. C., Ihnat, M. A., et al. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.11.006 · Cited by 15
Self-citationNaumann, J. M., Messinger, J., & Bureik, M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.08.004 · Cited by 15
3α-Hydroxysteroid Dehydrogenase Type III Deficiency: A Novel Mechanism for Hirsutism
Steiner, A. Z., Chang, L., Ji, Q., Ookhtens, M., Stolz, A., Paulson, R. J., & Stanczyk, F. Z. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2708 · Cited by 15
Brožič, P., Cesar, J., Kovač, A., Davies, M., Johnson, A. P., Fishwick, C. W. G., Rižner, T. L., & Gobec, S. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.019 · Cited by 16
Paracrine-stimulated gene expression profile favors estradiol production in breast tumors
Amin, S. A., Huang, C., Reierstad, S., Lin, Z., Arbieva, Z. H., Wiley, E. L., Saborian, H., Haynes, B. P., Cotterill, H., Dowsett, M., et al. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.029 · Cited by 15
Frau, R., & Bortolato, M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.05.013 · Cited by 13
Developmental Considerations for the Use of Naltrexone in Children and Adolescents
Stancil, S. L., Abdel‐Rahman, S. M., & Wagner, J. (2021) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-26.7.675 · Cited by 14
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 14
Finkelstein, D., Lamba, V., Assem, M., Rengelshausen, J., Yasuda, K., Strom, S. C., & Schuetz, E. G. (2006) · Xenobiotica · doi:10.1080/00498250600861769 · Cited by 15
Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer
Schulze, J. J., Karypidis, H., & Ekström, L. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00151 · Cited by 15
Hill, M., Pařı́zek, A., Velíková, M., Kubátová, J., Kancheva, R. L., Dušková, M., Šimůnková, K., Klímková, M., Pašková, A., Žižka, Z., et al. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.077 · Cited by 13
Brown, K. A., Boerboom, D., Bouchard, N., Doré, M., Lussier, J. G., & Sirois, J. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01987 · Cited by 14
Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3
Möller, G., Temml, V., Cala, A., Gruet, O., Richomme, P., Séraphin, D., Viault, G., Kraus, L., Huber‐Cantonati, P., Schopfhauser, E., et al. (2022) · Metabolites · doi:10.3390/metabo12020099 · Cited by 16
Organic Stereochemistry. Part 8
Testa, B. (2013) · Helvetica Chimica Acta · doi:10.1002/hlca.201200476 · Cited by 13
Verheul, H. A. M., Timmer, C. J., van Iersel, M. L. P. S., Delbressine, L. P. C., & Kloosterboer, H. J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014159 · Cited by 14
Engineering steroid hormone specificity into aldo-keto reductases
Penning, T. M., Ma, H., & Jez, J. M. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00257-x · Cited by 14
Self-citationKrishnaiah, M., Jonnalagadda, S. K., Morsy, A., Duan, L., Chhonker, Y. S., Murry, D. J., Penning, T. M., & Trippier, P. C. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00732 · Cited by 13
Self-citationDetlefsen, A. J., Mesaros, C., Duan, L., & Penning, T. M. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0235 · Cited by 14
Self-citationAhlem, C. N., Kennedy, M. R., Page, T., Bell, D., Delorme, E., Villegas, S. L., Reading, C. L., White, S., Stickney, D. R., & Frincke, J. M. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9517-0 · Cited by 13
Zamora-Sánchez, C. J., Bello‐Alvarez, C., Rodríguez‐Dorantes, M., & Camacho‐Arroyo, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094996 · Cited by 12
Ilacqua, A., Francomano, D., & Aversa, A. (2018) · Endocrinology · doi:10.1007/978-3-319-44675-2_17 · Cited by 14
Combined Liquid Chromatography–Tandem Mass Spectrometry Analysis of Progesterone Metabolites
Sinreih, M., Zukunft, S., Sosič, I., Cesar, J., Gobec, S., Adamski, J., & Rižner, T. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117984 · Cited by 13
Kim, S., Shin, Y. S., Kang, M., Yoon, J., & Min, K. (2014) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2014.03.016 · Cited by 13
Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
Cabeza, M., Sánchez‐Márquez, A., Garrido, M., Ortiz, A. V. S., & Bratoeff, E. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160210125642 · Cited by 14
Androgen Pathway Related Gene Variants and Prostate Cancer Association in Auckland Men
Karunasinghe, N., Lange, K., Han, D. Y., Goudie, M., Zhu, S., Wang, A. H., Bishop, K. S., Ferguson, L. R., & Masters, J. (2013) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/1875692111311010005 · Cited by 12
Effects of androgen and progestin on the proliferation and differentiation of osteoblasts
Wu, X., & Zhang, M. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6772 · Cited by 13
Biotechnological Production of 20-alpha-Dihydrodydrogesterone at Pilot Scale
Naumann, J. M., Zöllner, A., Drăgan, C.-A., Messinger, J., Adam, J., & Bureik, M. (2011) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-011-9243-x · Cited by 13
Lou, Z., Johnson, J. V., & James, M. O. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00222-4 · Cited by 13
Large trans-ethnic meta-analysis identifies AKR1C4 as a novel gene associated with age at menarche
Sarnowski, C., Cousminer, D. L., Franceschini, N., Raffield, L. M., Jia, G., Fernández‐Rhodes, L., Grant, S. F. A., Hakonarson, H. H., Lange, L. A., Long, J., et al. (2021) · Human Reproduction · doi:10.1093/humrep/deab086 · Cited by 13
Discovery and Optimization of a Covalent AKR1C3 Inhibitor
Grams, R. J., 5, Seal, R. J., Veccia, J., & Hsu, K. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00050 · Cited by 12
El-Kabbani, O. A. L., Dhagat, U., Soda, M., Endo, S., Matsunaga, T., & Hara, A. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.076 · Cited by 12
Hein, R., Abbas, S., Seibold, P., Salazar, R., Flesch‐Janys, D., & Chang-Claude, J. C. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1772-z · Cited by 12
Liu, H., Bellemare, V., Labrie, F., & Luu-The, V. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.10.004 · Cited by 12
Nipple Aspirate Fluid Hormone Concentrations and Breast Cancer Risk
Chatterton, R. T., Heinz, R. E., Fought, A. J., Ivancic, D. Z., Shappell, C. N., Allu, S., Gapstur, S. M., Scholtens, D. M., Gann, P. H., & Khan, S. A. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0252-7 · Cited by 12
Huang, C., Li, F. X., Pan, S., Xu, C., Dai, J. Q., & Zhao, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7488 · Cited by 12
SULFATION PATHWAYS: Contribution of intracrine oestrogens to the aetiology of endometriosis
Piccinato, C. D. A., Malvezzi, H., Gibson, D. A., & Saunders, P. T. K. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0297 · Cited by 12
Matsumoto, K., Hasegawa, T., Kamei, T., Koyanagi, J., Takahashi, T., Akimoto, M., & Sugibayashi, K. (2014) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-014-0190-0 · Cited by 12
Uwai, K., Konno, N., Kitamura, S., Ohta, S., & Takeshita, M. (2005) · Chirality · doi:10.1002/chir.20197 · Cited by 12
The Androgen Cascade in Ageing Men: Blessing or Curse?
Schalken, J. A. (2003) · European Urology Supplements · doi:10.1016/j.eursup.2003.09.009 · Cited by 12
Saleem, N., Aziz, U., Ali, M., Liu, X., Alwutayd, K. M., Alshegaihi, R. M., Niedbała, G., Elkelish, A., & Zhang, M. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1159394 · Cited by 11
Pinna, G., & Bortolato, M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106438 · Cited by 12
Gazvoda, M., Beranič, N., Turk, S., Burja, B., Kočevar, M., Rižner, T. L., Gobec, S., & Polanc, S. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.045 · Cited by 11
Ofude, M., Mizokami, A., Kumaki, M., Izumi, K., Konaka, H., Kadono, Y., Kitagawa, Y., Shin, M., Zhang, J., Keller, E. T., et al. (2013) · PubMed · Cited by 11
Applying mass spectrometric methods to study androgen biosynthesis and metabolism in prostate cancer
Knuuttila, M., Hämäläinen, E. K., & POUTANEN, M. H. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0150 · Cited by 10
Gao, L., Bao, Z., Deng, H., Li, X., Li, J., Rong, Z., Yang, Y., Liu, L., Nie, D., Wang, G., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1724-9 · Cited by 11
Jiang, Y., Li, Y., Cheng, J., Ma, J., Li, Q., & Pang, T. (2020) · British Journal of Haematology · doi:10.1111/bjh.16253 · Cited by 11
Endo, S., Sanai, M., Horie, K., Matsunaga, T., Ishikura, S., Tajima, K., El-Kabbani, O. A. L., & Hara, A. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.08.011 · Cited by 11
Discovery of new inhibitors of aldo-keto reductase 1C1 by structure-based virtual screening
Brožič, P., Turk, S., Rižner, T. L., & Gobec, S. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.002 · Cited by 11
Approach to the Patient: Hirsutism
Azziz, R., Amiri, M., Bril, F., Joham, A. E., Keleştimur, F., Ottey, S., Сутурина, Л. В., Tay, C. T., Teede, H. J., Yıldız, B. O., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf226 · Cited by 15
Shaon, M. A., Ansari, F., Mahmud, Z., Tamanna, S., Ibrahim, M. N. B., Alam, N. F., Hossain, M. N., & Howlader, M. Z. H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318079 · Cited by 11
Straume, A. H., Knappskog, S., & Lønning, P. E. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.02.003 · Cited by 10
Nanjidsuren, T., Naidansuren, P., Park, C., Park, J.-J., Yun, S.-J., Sim, B., Kang, M., Lee, S., Chang, K., & Min, K. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.07.006 · Cited by 10
Witchel, S. F., & Plant, T. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00018-4 · Cited by 10
Sanai, M., Endo, S., Matsunaga, T., Ishikura, S., Tajima, K., El-Kabbani, O. A. L., & Hara, A. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.04.003 · Cited by 10
Rotinen, M., Villar, J., & Encı́o, I. (2012) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-012-0155-1 · Cited by 10
Zhang, C., Min, Z., Liu, X., Wang, C., Wang, Z., Shen, J., Tang, W., Zhang, X., Liu, D., & Xu, X. (2019) · FEBS Letters · doi:10.1002/1873-3468.13630 · Cited by 10
Canonical and Noncanonical Androgen Metabolism and Activity
Storbeck, K., & Mostaghel, E. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_11 · Cited by 10
Stoll, A., Iannone, M., Gregorio, G. D., Molaioni, F., de la Torre, X., Botrè, F., & Parr, M. K. (2020) · Metabolites · doi:10.3390/metabo10110463 · Cited by 10
Liu, X., Lian, X., Liu, X., Du, Y., Zhu, Y., Hu, M., Zhang, P., Liu, Y., & Zhou, Y. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02425-3 · Cited by 9
Šestić, T. L., Bekić, S. S., Marinović, M. A., Kvasnicová, M., Štenclová, T., Rárová, L., Ćelić, A. S., Petri, E. T., Ajduković, J. J., Strnad, M., et al. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117850 · Cited by 9
Sun, M., Zhou, Y., Zhuo, X., Wang, S., Jiang, S., Peng, Z., Kang, K., Zheng, X., & Sun, M. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000519 · Cited by 10
Park, Y., Choi, K., Kim, H., Lee, J., Park, G., & Kim, J. (2021) · Cosmetics · doi:10.3390/cosmetics8030063 · Cited by 9
Lu, J.-W., Lei, W., Ling, L., Wang, L.-Y., Lin, Y.-K., Zhang, F., Li, M.-D., Pan, F., Wang, W., & Sun, K. (2022) · Endocrinology · doi:10.1210/endocr/bqac148 · Cited by 10
New insights into the substrate inhibition of human 17β-hydroxysteroid dehydrogenase type 1
Li, T., Song, X., Stephen, P., Yin, H., & Lin, S. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106246 · Cited by 9
Physiology of Testicular Function
Wistuba, J., Neuhaus, N., & Nieschlag, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-31574-9_2 · Cited by 11
Watanabe, K., Kakefuda, A., Yasuda, M., Enjo, K., Kikuchi, A., Furutani, T., Naritomi, Y., Otsuka, Y., Okada, M., & Ohta, M. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.06.025 · Cited by 9
New enzymatic assay for the AKR1C enzymes
Beranič, N., Štefane, B., Brus, B., Gobec, S., & Rižner, T. L. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2012.12.003 · Cited by 11
Differentiation-dependent progesterone synthesis and metabolism in NT2-N human neurons
Pistritto, G., Papacleovoulou, G., Ragone, G., Cesare, S. D., Papaleo, V., Mason, J. I., & Barbaccia, M. L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.008 · Cited by 9
Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes
Alshogran, O. Y. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1376648 · Cited by 9
Molecular genetic analysis of AKR1C2-4 and HSD17B6 genes in subjects 46,XY with hypospadias
Mares, L., Vilchis, F., Chávez, B. A., & Ramos, L. (2020) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2020.07.001 · Cited by 9
Robic, A., Faraut, T., Fève, K., Djebali, S., Prunier, A., Larzul, C., & Liaubet, L. (2021) · Genes · doi:10.3390/genes12040551 · Cited by 9
Abbattista, M. R., Ashoorzadeh, A., Guise, C. P., Mowday, A. M., Mittra, R., Silva, S., Hicks, K. O., Bull, M. R., Jackson-Patel, V., Lin, X., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14121231 · Cited by 9
Key players in progesterone and testosterone action: the metabolizing enzymes
Giatti, S., Diviccaro, S., & Melcangi, R. C. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100319 · Cited by 9
Role of Human Aldo–Keto Reductases in the Nitroreduction of 1-Nitropyrene and 1,8-Dinitropyrene
Su, A. L., Mesaros, C., Krzeminski, J., El‐Bayoumy, K., & Penning, T. M. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00271 · Cited by 11
Self-citationDevelopmental Evaluation of Aldo-keto Reductase 1C3 Expression in the Cryptorchid Testis
Ashley, R., Yu, Z., Fung, K.-M. A., Frimberger, D. C., Kropp, B. P., Penning, T. M., & Lin, H. (2009) · Urology · doi:10.1016/j.urology.2009.09.046 · Cited by 9
Self-citationYoon, S. O., Lee, J., & Lee, S.-M. (2014) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-11-29 · Cited by 10
van Rooyen, D., du Toit, T., Toit, R. L.-D., Africander, D., Swart, P., & Swart, A. C. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.09.025 · Cited by 9
Bulant, J., Hill, M., Velíková, M., Yamamotová, A., Pavel Martasek, E., & Papežová, H. (2019) · Steroids · doi:10.1016/j.steroids.2019.108523 · Cited by 9
Cheng, Q., Chen, Q., Xu, J., & Yu, H. (2018) · Molecular Catalysis · doi:10.1016/j.mcat.2018.06.013 · Cited by 9
Kang, K. W., & Kim, Y. G. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008323262 · Cited by 9
Heredia, V. V., Kruger, R. G., & Penning, T. M. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00176-x · Cited by 9
Self-citationSynthesis, Enzyme Localization, and Regulation of Neurosteroids
Smith, S. S. (2003) · CRC Press eBooks · doi:10.1201/9780203508169.ch1 · Cited by 9
Janković, Ð. D., Šestić, T. L., Bekić, S. S., Savić, M. P., Ćelić, A. S., Scholda, J., Kopp, F. B., Marinović, M. A., Petri, E. T., & Ajduković, J. J. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106545 · Cited by 9
Huacachino, A. A., Chung, A., Sharp, K. A., & Penning, T. M. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106641 · Cited by 8
Self-citationAuiyawong, B., Narawongsanont, R., & Tantitadapitak, C. (2017) · The Protein Journal · doi:10.1007/s10930-017-9732-z · Cited by 8
Jia, Y., Domenico, J. M., Swasey, C. H., Wang, M., Gelfand, E. W., & Lucas, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097448 · Cited by 8
In vitro CAPE inhibitory activity towards human AKR1C3 and the molecular basis
Li, C., Zhao, Y., Zheng, X., Zhang, H., Zhang, L., Chen, Y., Li, Q., & Hu, X. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.012 · Cited by 8
Morikawa, Y., Miyazono, H., Kamase, K., Suenami, K., Sasajima, Y., Sato, K., Endo, S., Monguchi, Y., Takekoshi, Y., Ikari, A., et al. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00380-8 · Cited by 7
Human AKR1C3 binds agonists of GPR84 and participates in an expanded polyamine pathway
Dudkina, N., Park, H. B., Song, D., Jain, A., Khan, S. A., Flavell, R. A., Johnson, C. H., Palm, N. W., & Crawford, J. M. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.07.011 · Cited by 7
Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy
Cronin, S. J. F., Andrews, N. A., & Latrémolière, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1173599 · Cited by 7
Weinbauer, G. F., Luetjens, C. M., Simoni, M., & Nieschlag, E. (2009) · Springer eBooks · doi:10.1007/978-3-540-92963-5_2 · Cited by 8
Human aldo-keto reductases: structure, substrate specificity and roles in tumorigenesis
Ma, J., & Cao, D. (2011) · BioMolecular Concepts · doi:10.1515/bmc.2011.010 · Cited by 7
Chang, Y., Huang, T., Chuang, L., & Hwang, C. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.06.006 · Cited by 7
Ilacqua, A., Francomano, D., & Aversa, A. (2016) · Endocrinology · doi:10.1007/978-3-319-27318-1_17-1 · Cited by 7
The identification of new substrates of human DHRS7 by molecular modeling and in vitro testing
Zemanová, L., Kirubakaran, P., Pato, I. H., Navrátilová, H., & Vondrášek, J. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.07.012 · Cited by 7
Takenoshita, R., & Toki, S. (2004) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.124.857 · Cited by 7
Wan, R., Kong, X., Yang, Y., Tao, S., Chen, Y., Teichmann, A. T., & Wieland, F. H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105527 · Cited by 7
Metadata
- Authors
- PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-09-26
- Volume
- 351
- Issue
- 1
- Pages
- 67-77
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221336
- OpenAlex
- W2045040068
- Cited by
- 649
- References
- 38
- Citations by year
- 2026: 21 · 2025: 20 · 2024: 23 · 2023: 15 · 2022: 15 · 2021: 27 · 2020: 19 · 2019: 22 · 2018: 23 · 2017: 18 · 2016: 23 · 2015: 14 · 2014: 47 · 2013: 28 · 2012: 29
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-47015, R01DK047015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- 3α-hydroxysteroid dehydrogenase, aldo-keto reductase superfamily, steroid hormone metabolism, dihydrotestosterone, testosterone, estradiol, progesterone, 20alpha-dihydroprogesterone, 3α-androstanediol, enzyme kinetic parameters, substrate specificity
- MeSH terms
- Androgens, Binding Sites, Catalysis, Cloning, Molecular, Estrogens, Female, Humans, Isoenzymes, Ketones, Kinetics, Male, Organ Specificity, Progestins, Recombinant Proteins, RNA, Messenger, Steroids, Substrate Specificity, 3-Hydroxysteroid Dehydrogenases, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
